DEF 14AThe Ballot
Theriva Biologics, Inc. files DEF 14A
Filed Mar 16, 2026 · 3mo ago · Accession 0001104659-26-028593
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Theriva Biologics, Inc.
- Ticker
- TOVX
- CIK
- 894158
- Form type
- DEF 14A
- Filing date
- Mar 16, 2026
- Report date
- Apr 9, 2026
- Document
- tm267779-2_def14a.htm
- Size
- 764 KB